R. Maini, S. Clair, E. W. Breedveld, F. Furst, D. Kalden et al., Infliximab (chimeric anti-tumour necrosis factor a monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial, Lancet, vol.354, pp.1932-1971, 1999.

M. Elliott, R. Maini, M. Feldmann, J. R. Kalden, and A. C. Smolen, Randomised doubleblind comparison of chimeric monoclonal antibody to tumour necrosis factor, Lancet, vol.344, p.8930, 1994.

M. E. Weinblatt, E. C. Keystone, D. E. Furst, L. W. Moreland, M. H. Weisman et al.,

, Adalimumab, a fully human antitumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial, Arthritis Rheum, vol.48, pp.35-45, 2003.

L. Klareskog, D. Van-der-heijde, J. P. Jager, A. Gough, J. Kalden et al., Therapeutic effect of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double blind randomized controlled trial, Lancet, vol.363, pp.675-81, 2004.

T. Pincus, B. Richardson, V. Strand, and M. J. Bergman, Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents, Clin Exp Rheumatol, vol.32, issue.5, pp.47-54, 2014.

T. L. Michaud, Y. H. Rho, T. Shamliyan, K. M. Kuntz, and H. K. Choi, The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis: a meta-analysis update of 44 trials, Am J Med, vol.127, pp.1208-1240, 2014.

J. P. Jansen, F. Buckley, F. Dejonckheere, and S. Ogale, Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with inadequate response to conventional DMARDs-a systematic review and network meta-analysis, Health Qual Life Outcomes, vol.12, p.102, 2014.

Z. Tutuncu, G. Reed, and J. Kremer, Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?, Ann Rheum Dis, vol.65, pp.1226-1235, 2006.

M. Ogasawara, N. Tamura, and S. Onuma, Observational cross-sectional study revealing less aggressive treatment in Japanese elderly than nonelderly patients with rheumatoid arthritis, J Clin Rheumatol, vol.16, pp.370-374, 2010.

S. Alivernini, D. Mazzotta, A. Zoli, and G. Ferraccioli, Leflunomide Treatment in Elderly Patients with Rheumatoid or Psoriatic Arthritis; Retrospective Analysis of Safety and Adherence to Treatment, Drugs Aging, vol.26, pp.395-402, 2009.

V. Ranganath and D. E. Furst, Disease-Modifying Antirheumatic Drug Use in the Elderly Rheumatoid Arthritis Patient, Clin Geriatr Med, vol.21, pp.649-69, 2005.

B. J. Radovits, W. Kievit, and R. F. Laan, Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety, Drugs Aging, vol.26, pp.647-64, 2009.

M. Soubrier, Z. Tatar, M. Couderc, S. Mathieu, and J. J. Dubost, Rheumatoid Arthritis in the Elderly in the Era of Tight Control Rheumatoid Arthritis in the Elderly in the Era of Tight Control, Drugs Aging, vol.30, pp.863-69, 2013.

J. M. Bathon, R. M. Fleischmann, and D. Van-der-heijde, Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis, J Rheumatol, vol.33, pp.234-277, 2006.

M. D. Köller, D. Aletaha, and J. Funovits, Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients. Rheumatology (Oxford), vol.48, pp.1575-80, 2009.

R. M. Fleischmann, S. W. Baumgartner, and E. A. Tindall, 6 auteurs al. Response to etanercept (Enbrel_) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results, J Rheumatol, vol.30, pp.691-96, 2003.

J. M. Fleischmann and R. M. , Van der Heijde D, 6 auteurs al. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis, J Rheumatol, vol.33, pp.234-277, 2006.

A. Saraux, J. Benichou, L. Guillevin, L. Idbrik, C. Job-deslandre et al., Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-? antagonists in France? The CORPUS cohort study, Clin Exp Rheumatol, vol.33, pp.602-612, 2015.

F. C. Arnett, S. M. Edworthy, D. A. Bloch, D. J. Mcshane, J. F. Fries et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, vol.31, pp.315-339, 1988.

M. L. Prevoo, M. A. Van-'t-hof, H. H. Kuper, M. A. Van-leeuwen, L. B. Van-de-putte et al., Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, vol.38, pp.44-52, 1995.

J. F. Fries, P. Spitz, R. G. Kraines, and H. R. Holman, Measurement of patient outcome in arthritis, Arthritis Rheum, vol.23, pp.137-182, 1980.

T. Sokka, H. Kautiainen, S. Toloza, H. Mäkinen, S. Verstappen et al., QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries, Ann Rheum Dis, vol.66, pp.1491-96, 2007.

T. Sokka, S. Toloza, M. Cutolo, H. Kautiainen, H. Makinen et al., Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study, Arthritis Res Ther, vol.11, p.7, 2009.

A. Ruyssen-witrand, B. Fautrel, A. Saraux, L. Loët, X. Pham et al., Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review, Jt Bone Spine Rev Rhum, vol.78, pp.23-30, 2011.

J. Listing, J. Kekow, B. Manger, G. Burmester, D. Pattloch et al., Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNF? inhibitors and rituximab, Ann Rheum Dis, vol.74, pp.415-436, 2015.

T. Sugihara, T. Ishizaki, and T. Hosoya, Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE), Rheumatology (Oxford), vol.54, pp.798-807, 2015.